Dolobid Tablet, Film Coated
Product Images NDC 74157-009

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dolobid (NDC 74157-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ina Pharmaceutics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250mg-100s (250mg 100s)

250mg-100s (250mg 100s)
Dolobid 250 mg (Diflunisal) film-coated tablets label by INA Pharmaceutics Inc. The label shows 60 tablets per container, NDC 74157-009-60, with storage instructions and pharmacist dispensing guidance. Manufactured for INA Pharmaceutics Inc., Fairmont, WV.*
FDA Label Image

375mg-100s (375mg 100s)

375mg-100s (375mg 100s)
Label for Dolobid 375 mg film-coated tablets containing Diflunisal. The label indicates a package of 60 tablets for oral use, manufactured for INA Pharmaceutics Inc. It features dosage instructions to see the package insert, storage conditions, and warnings about child-resistant closure and medication safety. The NDC 74157-101-60 and a barcode are also visible.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Diflunisal showing two fluorine atoms attached to a biphenyl core with two hydroxyl groups and one carboxyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.